Showing 1 - 20 results of 66 for search 'Lawrie, A', query time: 0.75s
Refine Results
-
1
Xenopus phospho-CDK7/cyclin H expressed in baculoviral-infected insect cells. by Lawrie, A, Tito, P, Hernandez, H, Brown, N, Robinson, C, Endicott, J, Noble, M, Johnson, L
Published 2001Journal article -
2
A three-antigen Plasmodium falciparum DNA prime—Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infectio... by Sklar, MJ, Maiolatesi, S, Patterson, N, Berrie, E, Bellamy, D, Bittaye, M, Ewer, K, Lawrie, A, Hill, A
Published 2021Journal article -
3
Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African children and infants by Bliss, C, Hodgson, S, Anagnostou, N, Duncan, C, Roberts, R, Lawrie, A, Imoukhuede, E, Ewer (nee Russell), K, Hill, A
Published 2016Journal article -
4
Viral vector malaria vaccines induce high-level T cell and antibody responses in West African children and infants by Bliss, C, Drammeh, A, Bowyer, G, Edwards, N, Hill, A, Hodgson, S, Roberts, R, Duncan, C, Lawrie, A, Imoukhuede, E, Ewer, K
Published 2016Journal article -
5
Safety and immunogenicity of malaria vectored vaccines given with routine EPI vaccines in Gambian infants and neonates: a randomized controlled trial by Mensah, V, Roetynck, S, Kanteh, E, Bowyer, G, Bliss, C, Roberts, R, Gerry, S, Lawrie, A, Imoukhuede, E, Ewer (nee Russell), K, Hill, A
Published 2017Journal article -
6
NEUTRALIZING ANTIBODY TITERS TO SIMIAN ADENOVIRAL VECTORS FOLLOWING ADCH63 ME-TRAP IMMUNIZATION IN HUMANS by Goodman, A, O'Hara, G, Ewer, K, Collins, K, Edwards, N, Reyes-Sandoval, A, Lawrie, A, Nicosia, A, Colloca, S, Gilbert, S, Hill, A
Published 2009Conference item -
7
Prime-boost vectored malaria vaccines: progress and prospects. by Hill, A, Reyes-Sandoval, A, O'Hara, G, Ewer, K, Lawrie, A, Goodman, A, Nicosia, A, Folgori, A, Colloca, S, Cortese, R, Gilbert, S, Draper, S
Published 2010Journal article -
8
A Phase Ia study to assess the safety and immunogenicity of new malaria vaccine candidates ChAd63 CS administered alone and with MVA CS by De Barra, E, Hodgson, S, Ewer, K, Bliss, C, Hennigan, K, Collins, A, Berrie, E, Lawrie, A, Gilbert, S, Nicosia, A, McConkey, S, Hill, A
Published 2014Journal article -
9
Comparison of the safety and immunogenicity of a candidate TB vaccine, MVA85A, given by the intramuscular or intradermal route in BCG-vaccinated adults by Harris, S, Meyer, J, Satti, I, Kostov, M, Rowland, R, Poulton, I, Poyntz, H, Tanner, R, Lillie, P, Lawrie, A, Hill, A, Mcshane, H
Published 2011Conference item -
10
A review of the tolerability of the candidate TB vaccine, MVA85A compared with BCG and Yellow Fever vaccines, and correlation between MVA85A vaccine reactogenicity and cellular imm... by Rowland, R, Brittain, N, Poulton, I, Minassian, A, Sander, C, Porter, D, Williams, N, Satti, I, Pathan, A, Lawrie, A, McShane, H
Published 2012Journal article -
11
Efficacy and safety of a modified Vaccinia Ankara-NP+M1 vaccine combined with QIV in people aged 65 and older: a randomised controlled clinical trial (INVICTUS) by Butler, C, Ellis, C, Folegatti, P, Swayze, H, Allen, J, Lawrie, A, Yu, L, Shanyinde, M, Bellamy, D, Mair, C, Flaxman, A, Ewer, KJ, Gilbert, S
Published 2021Journal article -
12
Safety and immunogenicity of the heterologous prime-boost ebolavirus vaccine regimen CHAD3-EBO Z and MVA-BN (R) FILO in healthy UK adults by Rampling, T, Ewer, K, Bowyer, G, Wright, D, Venkatraman, N, Payne, R, Nicosia, A, Sullivan, N, Graham, B, Pollard, A, Draper, S, Ballou, R, Lawrie, A, Gilbert, S, Hill, A
Published 2015Journal article -
13
Safety and high level efficacy of the combination malaria vaccine regimen of RTS,S/AS01B with ChAd-MVA vectored vaccines expressing ME-TRAP by Rampling, T, Ewer, K, Bowyer, G, Bliss, C, Edwards, N, Wright, D, Payne, R, Venkatraman, N, Snudden, C, Poulton, I, Roberts, R, Sinden, R, Gerry, S, Lawrie, A, Gilbert, S, Hill, A
Published 2016Journal article -
14
Alternate aerosol and systemic immunisation with a recombinant viral vector for tuberculosis, MVA85A: A phase I randomised controlled trial by Manjaly Thomas, Z, Satti, I, Marshall, J, Harris, S, Lopez Ramon, R, Hamidi, A, Minhinnick, A, Riste, M, Stockdale, L, Lawrie, A, Vermaak, S, Wilkie, M, Bettinson, H, McShane, H
Published 2019Journal article -
15
Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured onthe AGE1.CR.pIX Avian Cell Line by Folegatti, P, Bellamy, D, Flaxman, A, Mair, C, Ellis, C, Ramon, R, Lopez, F, Mitton, C, Baker, M, Poulton, I, Lawrie, A, Roberts, R, Minassian, A, Ewer, K, Evans, T, Hill, A, Gilbert, S
Published 2019Journal article -
16
Safety and Immunogenicity of a Novel Recombinant Simian Adenovirus ChAdOx2 as a Vectored Vaccine by Folegatti, P, Bellamy, D, Roberts, R, Powlson, J, Edwards, N, Mair, C, Bowyer, G, Poulton, I, Mitton, C, Green, N, Berrie, E, Lawrie, A, Hill, A, Ewer, K, Hermon-Taylor, J, Gilbert, S
Published 2019Journal article -
17
Toll-like receptor 3 is a therapeutic target for pulmonary hypertension by Farkas, D, Thompson, AAR, Bhagwani, AR, Hultman, S, Ji, H, Kotha, N, Farr, G, Arnold, ND, Braithwaite, A, Casbolt, H, Cole, JE, Sabroe, I, Monaco, C, Cool, CD, Goncharova, EA, Lawrie, A, Farkas, L
Published 2018Journal article -
18
Safety and immunogenicity of adenovirus and poxvirus vectored vaccines against a Mycobacterium avium complex subspecies by Folegatti, P, Flaxman, A, Jenkin, D, Makinson, R, Kingham, L, Bellamy, D, Ramos Lopez, F, Sheridan, J, Poulton, I, Aboagye, J, Tran, N, Mitton, C, Roberts, R, Lawrie, A, Hill, A, Ewer, KJ, Gilbert, S
Published 2021Journal article -
19
A first-in-human phase 1 trial to evaluate the safety and immunogenicity of the candidate tuberculosis vaccine MVA85A-IMX313, administered to BCG-vaccinated adults. by Minhinnick, A, Satti, I, Harris, S, Wilkie, M, Sheehan, S, Stockdale, L, Lopez-Ramon, R, Poulton, I, Lawrie, A, Vermaak, S, Le Vert, A, Del Campo, J, Hill, F, Moss, P, McShane, H, Manjaly Thomas, Z
Published 2016Journal article -
20
Identification of novel purine and pyrimidine cyclin-dependent kinase inhibitors with distinct molecular interactions and tumor cell growth inhibition profiles. by Arris, C, Boyle, F, Calvert, A, Curtin, N, Endicott, J, Garman, E, Gibson, A, Golding, B, Grant, S, Griffin, R, Jewsbury, P, Johnson, L, Lawrie, A, Newell, DR, Noble, M, Sausville, E, Schultz, R, Yu, W
Published 2000Journal article